Cervical cancer screening is an essential component of preventative health care. Although rates of cervical cancer have decreased over the last 50 years, survival has not changed dramatically, and there are significant discrepancies in disease detection by race. Multiple national organizations contribute to the recommendations for cervical cancer screening timing, testing modalities, and management. This article aims to summarize the current understanding of cervical cancer pathogenesis, options for cervical cancer screening, and the shift in guidelines toward risk-based clinical management.
Keywords: Cervical cancer; Co-testing; Human papillomavirus; Pap smear; Primary HPV testing; Screening.
Copyright © 2022 Elsevier Inc. All rights reserved.